PTH and Marchiafava-Bignami disease: Nonetheless, treatment decisions should be guided by the presence of chronic kidney disease-mineral and bone disorder (CKD-MBD), as indicated by abnormal calcium, phosphate, PTH, alkaline phosphatase, or calcifediol levels.